Fujifilm Corporation said it has selected Holly Springs, NC as the location for its new large-scale cell culture production site in the U.S. The previously announced investment of more $2 billion to establish the largest end-to-end cell culture biopharmaceutical contract development and manufacturing organization (CDMO) facility in North America will create 725 highly-skilled jobs in the area by the end of 2028. Fujifilm Diosynth Biotechnologies, a subsidiary of Fujifilm Corporation, with develo...